Metabasis names new board member

Dr Stoner brings extensive global clinical research and development experience from her 22-year tenure at Merck Research Laboratories, as well as from her years in academic medicine. She will also be joining Metabasis’s Scientific Advisory Board.

Dr Stoner held various key executive roles while at Merck Research Laboratories, most recently as senior vice president for global clinical development operations. In that role, she was responsible for the company’s clinical development activity in over 40 countries.

David Hale, chairman of the board at Metabasis, said: “Dr Stoner’s experience and background will be an invaluable asset to the company. Her exceptional credentials, extensive knowledge of clinical development and experience with metabolic diseases will be invaluable as we continue work on our core product candidates currently in clinical development for type 2 diabetes and hyperlipidemia.”